IBD and Obesity: Is There a Connection?
One key factor that has developed increasing research interest is the role of a patient’s BMI, specifically those with obesity (BMI > 30 kg/m2), in the development of IBD.
One key factor that has developed increasing research interest is the role of a patient’s BMI, specifically those with obesity (BMI > 30 kg/m2), in the development of IBD.
Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.
In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.
Although the definition of remission varies, the goal of IBD treatment is to achieve and sustain remission.
Vitamin D is a biomarker of interest in the pancreatic cancer setting.